J Immunol Methods
-
Publication Venue For
- Validation of the performance and suitability of a new class of FBS optimized for use in single-cell functional assays.. 515:113452. 2023
- A novel method for in vitro culture and expansion of nonhuman primate B cells.. 511:113363. 2022
- Broad immunophenotyping of the murine brain tumor microenvironment.. 499:113158. 2021
- Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies.. 479:112764. 2020
- Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs.. 479:112736. 2020
- A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis.. 459:90-93. 2018
- Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV.. 455:24-33. 2018
- Development and validation of a cell-based fluorescent method for measuring antibody affinity.. 442:49-53. 2017
- Fluorescence-based measurement of cystine uptake through xCT shows requirement for ROS detoxification in activated lymphocytes.. 438:51-58. 2016
- Variability of the IFN-γ ELISpot assay in the context of proficiency testing and bridging studies.. 433:69-76. 2016
- Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.. 409:62-71. 2014
- Development of a contemporary globally diverse HIV viral panel by the EQAPOL program.. 409:117-130. 2014
- Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.. 409:107-116. 2014
- Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL).. 409:91-98. 2014
- Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.. 409:1-5. 2014
- Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs.. 409:99-106. 2014
- Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.. 409:147-160. 2014
- Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.. 409:131-146. 2014
- Setting objective thresholds for rare event detection in flow cytometry.. 409:54-61. 2014
- Statistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry.. 409:72-81. 2014
- The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.. 409:21-30. 2014
- The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.. 409:31-43. 2014
- The Immunology Quality Assessment Proficiency Testing Program for CD3⁺4⁺ and CD3⁺8⁺ lymphocyte subsets: a ten year review via longitudinal mixed effects modeling.. 409:82-90. 2014
- Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays.. 409:44-53. 2014
- Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen.. 404:1-12. 2014
- A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profiling.. 395:1-13. 2013
- Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis.. 395:14-20. 2013
- Interference of thrombin in immunological assays for hirudin specific antibodies.. 381:50-58. 2012
- Screening the interactions between HIV-1 neutralizing antibodies and model lipid surfaces.. 376:13-19. 2012
- Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.. 375:57-67. 2012
- Flow cytometric methods for prenatal and neonatal diagnosis.. 363:198-209. 2011
- Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays.. 363:42-50. 2010
- Stromal cell independent B cell development in vitro: generation and recovery of autoreactive clones.. 354:53-67. 2010
- Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy.. 345:90-99. 2009